Unknown

Dataset Information

0

Ginseng Berry Extract Attenuates Dextran Sodium Sulfate-Induced Acute and Chronic Colitis.


ABSTRACT: This study investigates the in vivo functions of ginseng berry extract (GB) as a therapy for dextran sodium sulfate (DSS)-induced colitis. C57BL/6 mice were given drinking water containing DSS (3%) for eight days to induce acute colitis. At the same time, the mice received an oral dose of GB (50 mg/kg) once daily. The GB-treated mice were less susceptible to the development of acute colitis than were control mice treated with saline, as determined by weight loss, disease activity, and colon histology. The administration of GB to DSS-treated mice also reduced the numbers and inhibited the activation of colon-infiltrating T cells, neutrophils, intestinal CD103(-)CD11c? dendritic cells (cDCs), and macrophages. In addition, GB treatment promoted the migration of CD103?CD11c? cDCs and expansion of Foxp3? regulatory T cells in the colons of DSS-treated mice. Similarly, in the DSS-induced chronic colitis model, GB treatment improved the macroscopic and histological appearance of the colon wall when compared to untreated control mice, as indicated by longer colon length and lower histological scores. This is the first report to show that oral administration of GB suppresses immune activation and protects against experimentally induced colitis.

SUBMITTER: Zhang W 

PROVIDER: S-EPMC4848668 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ginseng Berry Extract Attenuates Dextran Sodium Sulfate-Induced Acute and Chronic Colitis.

Zhang Wei W   Xu Li L   Cho Si-Young SY   Min Kyung-Jin KJ   Oda Tatsuya T   Zhang LiJun L   Yu Qing Q   Jin Jun-O JO  

Nutrients 20160405 4


This study investigates the in vivo functions of ginseng berry extract (GB) as a therapy for dextran sodium sulfate (DSS)-induced colitis. C57BL/6 mice were given drinking water containing DSS (3%) for eight days to induce acute colitis. At the same time, the mice received an oral dose of GB (50 mg/kg) once daily. The GB-treated mice were less susceptible to the development of acute colitis than were control mice treated with saline, as determined by weight loss, disease activity, and colon hist  ...[more]

Similar Datasets

| S-EPMC3667021 | biostudies-literature
| S-EPMC10806049 | biostudies-literature
| S-EPMC8399719 | biostudies-literature
| S-EPMC4524530 | biostudies-literature
| S-EPMC7655509 | biostudies-literature
| S-EPMC9536985 | biostudies-literature
| S-EPMC4008378 | biostudies-literature
| S-EPMC8510245 | biostudies-literature
| S-EPMC7063356 | biostudies-literature
| S-EPMC8766511 | biostudies-literature